Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032519 · ClinicalTrials.gov registry record · NA
Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT07032519 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 54 participants.
The verdict
NCT07032519, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments only through the app. The MBI intervention includes weekly video content focused on mindfulness practice and psychoeducation, combined with daily symptom tracking through the app. Participants in both groups will complete self-report measures at baseline, post-intervention, and follow-ups at 3 and 6 months. The study will enroll up to 100 participants from Brigham and Women's Hospital and the greater Boston area. This pilot study is designed to assess feasibility and explore preliminary effects on outcomes such as pain interference, fibromyalgia symptoms, pain catastrophizing, sleep disturbance, emotional distress, mindfulness, and pain acceptance. Results will be used to inform the design of a future fully powered randomized trial.
Interventions
- BEHAVIORAL Mindfulness Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-05-03 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07032519
The ClinicalTrials.gov registry entry for NCT07032519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Intervention is the first listed.
NCT07032519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07032519 about?
NCT07032519 is a clinical study titled "Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App". The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments on...
What is the current status of trial NCT07032519?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2024-05-03. Estimated completion is 2025-08-01.
What interventions are being tested in trial NCT07032519?
The interventions under investigation include: Mindfulness Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07032519?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.